Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.

Pharmaceutical

Cipla

Umang Vohra

Deepak Viegas

Vijayasarathi Ramaswami

Raju Mistry

Ashish Musaddi

The board of directors at Cipla consists of individuals with various backgrounds in investment management and consulting. These individuals have experience working for companies such as Goldman Sachs and have received education from institutions such as .

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Cipla

Leadership Team

CEO and Executive Team